A Growth Hormone Drug Gets a Second Look as a Seizure Treatment
Pediatric endocrinology is the branch of medicine that looks after hormones in children. It covers...
A Growth Hormone Drug Gets a Second Look as a Seizure Treatment
73
Pediatric endocrinology is the branch of medicine that looks after hormones in children. It covers growth, puberty, blood sugar, adrenal...
The Race to Treat Peanut Allergy Gets Another Contender
155
Food allergy costs far more than most people assume. A 2025 study led by Christopher Warren, published in the Journal...
Azenta Expands GENEWIZ With Licensed and Acquired DNA Technology
107
A life sciences company that helps researchers study genes and develop new therapies has made two moves intended to give...
A Late-Stage Leukemia Trial Reaches its Final Analysis Point
120
Acute myeloid leukemia, commonly called AML, is a cancer of the blood and bone marrow. It begins when immature white...
Bioengineered Human Tissues Move from Laboratory Promise to Surgical Use
137
Bioengineered human tissues sit at the meeting point of biology, engineering, and manufacturing. Instead of relying only on donor organs,...
Rapport Secures New Funding for Precision Brain Drug Development
189
Many medicines work by interacting with specific proteins in the body, but small molecule precision medicines take that idea further....
Why Immuno Inflammatory Diseases Are a Major Focus for Drug Developers
200
The human immune system is designed to recognize and respond to threats such as infections and injuries. In immuno-inflammatory diseases,...
Why Your Next Health Check Might Happen at Home
154
For most of modern history, checking on your health meant going somewhere: a clinic, a lab, a hospital waiting room....
Aardvark Therapeutics Moves Past a Major FDA Roadblock
169
Before a new medicine can be sold in the United States, it must move through a carefully controlled process of...
Kidney Cancer’s Global Toll Drives Interest in a New Targeted Radiotherapy Approach
154
Kidney cancer is one of the more common cancers worldwide, yet it often receives less public attention than breast, lung,...
Rapport Therapeutics Advances Bipolar Mania Program After Encouraging Trial Results
235
Bipolar disorder remains one of psychiatry’s most difficult conditions to treat, and Rapport Therapeutics’ (NASDAQ: RAPP) latest Phase 2 results...
Oral RIPK2 Inhibitor Shows Promise in Ulcerative Colitis Trial
140
Autoimmune and inflammatory diseases occur when the immune system does not return to its normal, regulated state after responding to...
Jyong Biotech Weighs Texas for Its First U.S. Manufacturing Footprint
194
A Taiwan-based biotechnology company is taking a step that could bring its experimental prostate treatments closer to the U.S. market....
Pancreatic Cancer Survival Has Stalled and One Small Biotech is Testing a...
405
Pancreatic cancer claims more American lives each year than all but two other cancers. The American Cancer Society estimates that...
Industrial Automation Moves into Drug Development
333
Every medicine comes with a recipe, and the recipe is far longer than most people would guess. Before a drug...
